אודות פרק זה
This episode’s Community Champion Sponsor is Ossur. To learn more about their ‘Responsible for Tomorrow’ Sustainability Campaign, and how you can get involved: CLICK HERE
Episode Overview:
Breakthroughs in drug discovery don't come from any single discipline.
They come from the rare few who have built deep expertise across multiple domains and know how to bring those layers together.
Tara Austraat-Churik is doing exactly that as Partner at Blue Matter, where she leads the firm's first R&D practice at the intersection of drug discovery, clinical development, and AI-driven transformation.
With a career spanning government intelligence, pharmacovigilance, IBM Watson Health, and Ernst Young, Tara has developed what she calls Compound Expertise, depth earned repeatedly across fields that compounds into judgment no single path can produce.
Join us to discover how she and the Blue Matter team are helping biopharma organizations reimagine the future of R&D, navigate the AI transformation ahead, and keep the patient at the center of it all. Let's go!
Episode Highlights:
- Tara's "compound expertise" across government intelligence, IBM, EY, and pharma fuels her unique R&D consulting approach.
- Blue Matter's R&D practice is built on scientific depth, AI-driven tools, and ecosystem partnerships, not generic consulting frameworks.
- Tara predicts R&D workforces will shrink in headcount but grow in capability, with leaders managing both humans and AI agents.
- The biggest AI transformation mistake: treating it as a technology problem rather than a decision-making transformation.
- True client partnership happens when clients call for off-scope advice, trusting your judgment beyond any formal deliverable.
About our Guest:
Tara Austraat-Churik is a Partner at Blue Matter, where she leads the firm's R&D practice at the intersection of drug discovery, clinical development, and AI-driven transformation.
Over a twenty-plus year career, she has built expertise across government intelligence, drug safety, enterprise technology, and life sciences — serving in roles including Acting General Manager of a $6 billion IBM consulting division and Managing Director of Health, Science, and Wellness at EY. She holds an MSc in Translational Medicine from the University of Edinburgh.
Tara's work is guided by what she calls Compound Expertise: depth earned repeatedly across domains, compounding into the kind of judgment no single discipline can provide. She believes the most meaningful breakthroughs happen at the intersection of fields — and that each one represents a life that might be changed.
Links Supporting This Episode:
- Blue Matter page: CLICK HERE
- Tara Austraat-Churik LinkedIn page: CLICK HERE
- Blue Matter LinkedIn page: CLICK HERE
- Mike Biselli LinkedIn page: CLICK HERE
- Mike Biselli Twitter page: CLICK HERE
- Visit our website: CLICK HERE
- Subscribe to newsletter: CLICK HERE
- Guest nomination form: CLICK HERE
